Botulinum Therapy Provides Relief for Many Neurological Conditions
"Botulinum toxin is providing success in treating a variety of neurological conditions, many of which are otherwise incapacitating," says Diego Torres-Russotto, MD, neurologist and medical director of the Botulinum Toxin Therapy Clinic at Nebraska Medicine. "Botox is an underutilized treatment that has a good safety profile with very minor side effects."
Botulinum toxin treatments are being used to help patients overcome debilitating movement and non-movement disorders. This includes movement disorders such as: blepharospasm, cervical dystonia, writer's cramp, spasticity, hemi-facial spasm, severe intractable tremors and cerebral palsy; and non-movement disorders such as chronic migraines, excessive drooling and severe bothersome sweating.
"In some of these conditions, botulinum toxin therapy has become the preferred treatment of choice because of its high efficacy and low side effects," says Dr. Torres. Injections are generally required every three to four months. The therapy can be used to treat symptoms in both adults and children. Patients will experience varying levels of relief and therapeutic benefit.
Botox is FDA approved for blepharospasm, cervical dystonia, chronic migraine, upper limb spasticity and many others.
Patients benefit from the fact that they are seen by a multi-disciplinary team including physical therapy and rehabilitation. Other physicians in the clinic include neurologists Danish Bhatti, MD, Amy Hellman, MD and Pariwat Thaisetthawatkul, MD. "We have expertise in treating many of these conditions and are fellowship-trained in movement disorders and chemodenervation," says Dr. Torres.
The Movement Disorders Clinic at Nebraska Medicine is one of the most comprehensive, multidisciplinary programs in the region that combines specialists in neurology, neurosurgery, neuropsychology and physical, occupational and speech therapy.